Dexmedetomidine Hydrochloride
NDC 63323-421, dexmedetomidine hydrochloride, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-421
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201072
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-421 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXMEDETOMIDINE HYDROCHLORIDE100 ug/mL
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]; General Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-421-02 | 63323042102 | 25 VIAL in 1 TRAY (63323-421-02) / 2 mL in 1 VIAL (63323-421-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c1b8eb58-596b-481d-beb6-ba9d2237abf4
Use it
Look up 63323-421 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-421 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-421. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.